Online citations, reference lists, and bibliographies.
← Back to Search

Motor Neurone Disease And Animal Models

D. Price, D. Cleveland, V. Koliatsos
Published 1994 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Over the past several years, remarkable progress has been made in understanding the biological substrates of motor neurone disease (MND) (Kuncl et al 1992, Smith 1992, Williams & Windebank 1993). Genetic factors in the aetiology of MND have been identified, animal models have been developed and characterized, hypothetical pathogenetic mechanisms have been proposed and are being tested and promising therapeutic approaches are being explored.The investigation of MND is now one of the most exciting and challenging areas of research and provides a superb illustration of the dynamic interactions between clinical and basic research in neuroscience.
This paper references
10.1097/00005072-198405000-00004
Neurofilamentous Axonal Swellings as a Normal Finding in the Spinal Anterior Horn of Man and Other Primates
A. Clark (1984)
Hereditary spinal muscular atrophy in Brittany Spaniels: clinical manifestations.
M. Lorenz (1979)
10.1212/WNL.42.9.1724
Androgen receptor abnormality in X‐linked spinal and bulbar muscular atrophy
T. Matsuura (1992)
Motor neuron disease In: Peripheral Neuropathy, Third edition
Williams D B Windebank (1993)
Handbook of Amyotrophic Lateral Sclerosis, Neurological Disease and Therapy
R A Smith (1992)
10.1016/0092-8674(93)90151-F
Motor neurons and neurofilaments in sickness and in health
S. Brady (1993)
10.1073/PNAS.91.17.8292
Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity.
D. Borchelt (1994)
Changes in neuronal size and neurotransmitter marker in hereditary canine spinal muscular atrophy.
L. Cork (1989)
10.1007/BF01186993
Down's syndrome: morphological remodelling and increased complexity in the neuromuscular junction of transgenic CuZn-superoxide dismutase mice
K. Avraham (1991)
Axonal transport fin Hereditary Canine Spinal Muscular Atrophy (HCSMA)
Griffin J W Cork (1982)
Fine structural study of sporadic and familial amyotrophic lateral sclerosis
N. HoffmanP. (1992)
10.1083/JCB.122.6.1337
Neurofilaments are obligate heteropolymers in vivo
M. K. Lee (1993)
Excitatory amino acids as a final common pathway for neurologic disorders N
D. LorenzM. (1994)
Animal models of amyotrophic lateral sclerosis.
H. Mitsumoto (1995)
Changes in size of motor axons in hereditary canine spinal muscular atrophy.
L. Cork (1989)
10.1084/JEM.81.5.469
THE REGENERATIVE CYCLE OF MOTONEURONS, WITH SPECIAL REFERENCE TO PHOSPHATASE ACTIVITY
D. Bodian (1945)
10.1097/00005072-199405000-00002
Neurofilament Light and Polyadenylated mRNA Levels Are Decreased in Amyotrophic Lateral Sclerosis Motor Neurons
C. Bergeron (1994)
Targeted disruption of the BDNF gene perturbs brain and sensory neurone development but not motor
R. Klein (1994)
10.1016/0960-8966(93)90004-4
Accumulating autofluorescent material as a marker for early changes in the spinal cord of the Mnd mouse
A. Messer (1993)
10.1038/368193A0
Tracking neurotrophin function
A. Davies (1994)
Pathology of motor neurons in accelerated hereditary canine spinal muscular atrophy.
L. Cork (1982)
Expression of a mutant neurofilament subunit causes massive, selective motor neuron death and ALS-like motor neuron disease
M. K. Lee (1994)
10.1016/0006-8993(90)90832-V
Regulation of peripherin and neurofilament expression in regenerating rat motor neurons
C. Troy (1990)
10.1016/0014-4886(90)90140-N
Alterations in levels of mRNAs coding for neurofilament protein subunits during regeneration
N. Muma (1990)
10.1038/362059a0
Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
D. R. Rosen (1993)
10.1016/0304-3940(78)90145-3
Tetanus toxin: Immunocytochemical evidence for retrograde transport
P. Carroll (1978)
10.1038/344767A0
Gene for chronic proximal spinal muscular atrophies maps to chromosome 5q
J. Melki (1990)
10.1097/00005072-197905000-00002
HEREDITARY CANINE SPINAL MUSCULAR ATROPHY
L. Cork (1979)
10.1038/345440A0
Ciliary neurotrophic factor prevents the degeneration of motor neurons after axotomy
M. Sendtner (1990)
10.1097/00005072-198001000-00004
THE AXONAL PATHOLOGY IN CHRONIC IDPN INTOXICATION
A. Clark (1980)
10.1146/annurev.bi.44.070175.001051
Superoxide dismutases.
W. Beyer (1991)
10.1083/JCB.101.4.1332
Changes in neurofilament transport coincide temporally with alterations in the caliber of axons in regenerating motor fibers
P. Hoffman (1985)
10.1016/0166-2236(83)90233-3
Neurotoxic probes of the axonal cytoskeleton
J. Griffin (1983)
10.1136/jnnp.33.3.338
The central nervous system in motor neurone disease
B. Brownell (1970)
Spinal muscular atrophies: how many types?
I. Hausmanowa-Petrusewicz (1991)
10.1016/0888-7543(92)90155-L
Mapping of the motor neuron degeneration (Mnd) gene, a mouse model of amyotrophic lateral sclerosis (ALS).
A. Messer (1992)
Fine structural study of sporadic and familial amyotrophic lateral sclerosis. In:Handbook ofAmyotrophic Lateral Sclerosis
A. Hirano (1992)
The pathology of motor neurone disorders
B. Q. Banker (1986)
10.1073/PNAS.87.4.1561
Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport.
E. Koo (1990)
10.1038/362020a0
Did radicals strike Lou Gehrig?
J. McNamara (1993)
10.1073/PNAS.91.8.3304
Neurotrophin 4/5 is a trophic factor for mammalian facial motor neurons.
V. Koliatsos (1994)
Diseases of the basal ganglia , cerebellum and motor neurons
L. W. Duchen (1992)
Brain-derived neurotrophic factor prevents the death of motoneurones in newborn rats after nerve
M. Sendtner (1992)
10.1126/SCIENCE.8209258
Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation.
M. Gurney (1994)
Cytopathology of amyotrophic lateral sclerosis.
A. Hirano (1991)
10.1016/0006-8993(88)91054-2
Levels of neurotransmitter and cytoskeletal protein mRNAs during nerve regeneration in sympathetic ganglia
E. Koo (1988)
10.1056/NEJM199105163242001
Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity.
T. Siddique (1991)
10.1038/360216B0
Motor neuron disease model
G. Vrbóva (1992)
10.1111/j.1471-4159.1992.tb10990.x
Reactive Oxygen Species and the Central Nervous System
B. Halliwell (1992)
10.1097/00005072-198801000-00002
Accumulation of Phosphorylated Neurofilaments in Anterior Horn Motoneurons of Amyotrophic Lateral Sclerosis Patients
D. Munoz (1988)
10.3109/01677068709167181
Histopathology of the late-onset motor neuron degeneration (Mnd) mutant in the mouse.
A. Messer (1987)
10.1097/00005072-197703000-00002
THE PATHOGENESIS OF REACTIVE AXONAL SWELLINGS: ROLE OF AXONAL TRANSPORT
J. Griffin (1977)
10.1097/00005072-199105000-00002
A New Mouse Mutant with Progressive Motor Neuronopathy
H. Schmalbruch (1991)
10.1073/PNAS.91.10.4155
Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons.
J. Rothstein (1994)
10.1002/ANA.410320517
Severity of X‐linked recessive bulbospinal neuronopathy correlates with size of the tandem cag repeat in androgen receptor gene
M. Doyu (1992)
10.1083/JCB.88.1.205
Incorporation of axonally transported glycoproteins into axolemma during nerve regeneration
J. Griffin (1981)
10.1002/ANA.410180302
Amyotrophic lateral sclerosis: Part 1. Clinical features, pathology, and ethical issues in management
R. Tandan (1985)
10.1083/JCB.53.1.24
THE RESPONSE OF VENTRAL HORN NEURONS TO AXONAL TRANSECTION
D. Price (1972)
Diseases of the basal ganglia, cerebellum and motor neurons. In: Greenfield’s Neuropathology, Fifth edition
D. R. Oppenheimer (1992)
Cytoskeletal disorganization induced by local application of beta, beta'-iminodipropionitrile and 2,5-hexanedione.
J. Griffin (1983)
10.1083/JCB.99.2.705
Control of axonal caliber by neurofilament transport
P. Hoffman (1984)
10.1016/0092-8674(93)90157-L
Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease
Z. Xu (1993)
10.1016/S0303-8467(88)80052-0
Motor neurone diseases
J. Hausmanowapetrusewicz (1988)
10.1097/00005072-198205000-00096
AXONAL TRANSPORT IN HEREDITARY CANINE SPINAL MUSCULAR ATROPHY (HCSMA): 88
J. W. Griffin (1982)
10.1212/WNL.39.7.919
Linkage analysis in familial amyotrophic lateral sclerosis
T. Siddique (1989)
10.1002/NEU.480230913
Axotomy-induced neuronal death during development.
W. Snider (1992)
10.1016/S0092-8674(88)91153-1
Down's syndrome: Abnormal neuromuscular junction in tongue of transgenic mice with elevated levels of human Cu/Zn-superoxide dismutase
K. Avraham (1988)
10.1038/358502A0
Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuronopathy
M. Sendtner (1992)
Inherited neuronal atrophy and degeneration
A. E. Harding (1993)
Reactive oxygen species and the central nervous system. In: Free Radicals in the Brain. Aging, Neurological and Mental Disorders
B. 1772–1775. Halliwell (1992)
10.1038/360541C0
More on motor neurons
M. Sendtner (1992)
10.1523/JNEUROSCI.10-12-03801.1990
Mouse nerve growth factor prevents degeneration of axotomized basal forebrain cholinergic neurons in the monkey
V. Koliatsos (1990)
10.1016/0304-3940(91)90256-S
Ubiquitin deposits are present in spinal motor neurons in all stages of the disease in the motor neuron degeneration (Mnd) mutant of the mouse
J. Mazurkiewicz (1991)
Cytopathology of amyotrophic lateral sclerosis In: Amyotrophic Lateral Sclerosis and Other Motor Neuron Diseases
A Hirano (1991)
The response of motor neurons to injury and disease
Price D L Griffin (1984)
10.1016/0092-8674(94)90377-8
Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development
K. R. Jones (1994)
10.1016/0896-6273(93)90326-M
Evidence that brain-derived neurotrophic factor is a trophic factor for motor neurons in vivo
V. Koliatsos (1993)
10.1016/S0092-8674(05)80088-1
Targeted disruption of the trkB neurotrophin receptor gene results in nervous system lesions and neonatal death
R. Klein (1993)
10.1073/PNAS.90.14.6591
Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity.
J. Rothstein (1993)
The response of motor neurons to injury and disease
D. L. Price (1984)
Über die veranderungen der ganglienzellen am facialiskern des kanincheng anch ausreissung der nerven
W. OppenheimR. (1892)
10.1073/PNAS.84.10.3472
Neurofilament gene expression: a major determinant of axonal caliber.
P. Hoffman (1987)
10.1146/ANNUREV.PA.29.040189.002053
The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system.
D. Monaghan (1989)
10.1097/00005072-199107000-00009
Neurofilament Distribution is Altered in the Mnd (Motor Neuron Degeneration) Mouse
L. Callahan (1991)
10.1017/S0317167100032613
Hereditary canine spinal muscular atrophy: an animal model of motor neuron disease.
L. Cork (1991)
10.1056/NEJM199403033300907
Excitatory amino acids as a final common pathway for neurologic disorders.
S. Lipton (1994)
10.1111/j.1750-3639.1993.tb00726.x
Ubiquitin in Neurodegenerative Diseases
J. Lowe (1993)
Über die veranderungen der ganglienzellen am facialiskern des kanincheng anch ausreissung der nerven
F Nissl (1892)
10.1016/0006-8993(91)90471-7
Axotomy induces nerve growth factor receptor immunoreactivity in spinal motor neurons
V. Koliatsos (1991)
10.1016/0006-8993(86)90445-2
Structural correlates of physiological abnormalities in β,β′-Iminodipropionitrile
B. Gold (1986)
10.1212/WNL.38.7.1114
Swelling of neuronal processes in motor neuron disease
S. Sasaki (1988)
10.1097/00005072-198811000-00007
Phosphorylation of Neurofilaments Is Altered in Amyotrophic Lateral Sclerosis
V. Manetto (1988)
10.1097/00005072-198705000-00004
Distribution of Neurofilament Antigens after Axonal Injury
J. Rosenfeld (1987)
10.1038/365027A0
Disruption of the CNTF gene results in motor neuron degeneration
Y. Masu (1993)
Fine structural study of sporadic and familial amyotrophic lateral sclerosis
A Hirano (1992)
Slow axonal transport of neurofilament proteins: impairment by β,β'-iminodipropionitrile administration
Griffin J W Hoffman (1978)
10.1080/10715760600918142
Protein oxidation and aging
E. Stadtman (1992)
10.1016/0955-0674(94)90113-9
Neurofilament function and dysfunction: involvement in axonal growth and neuronal disease.
M. K. Lee (1994)
Handbook of Amyotrophic Lateral Sclerosis
R. Smith (1992)
10.1007/978-1-4471-1871-8
Motor Neuron Disease
P. Leigh (1995)
10.1126/SCIENCE.7910982
De novo and inherited deletions of the 5q13 region in spinal muscular atrophies.
J. Melki (1994)
10.1016/0092-8674(93)90158-M
Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: A mouse model of amyotrophic lateral sclerosis
F. Côté (1993)
10.1126/SCIENCE.3287616
DNA damage and oxygen radical toxicity.
J. Imlay (1988)
10.1083/JCB.111.4.1543
Expression of NF-L in both neuronal and nonneuronal cells of transgenic mice: increased neurofilament density in axons without affecting caliber
M. J. Monteiro (1990)
10.1038/360755A0
Brain-derived neurotrophic factor rescues developing avian motoneurons from cell death
R. Oppenheim (1992)
10.1016/0304-3940(77)90145-8
Tetanus toxin: Retrograde axonal transport of systemically administered toxin
D. Price (1977)
10.1016/0896-6273(94)90280-1
Neurofilament-deficient axons and perikaryal aggregates in viable transgenic mice expressing a neurofilament-β-galactosidase fusion protein
J. Eyer (1994)
A candidate gene for X-linked spinal muscular atrophy.
K. Fischbeck (1991)
10.1056/NEJM199205283262204
Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis.
J. Rothstein (1992)
10.1038/360757A0
Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section
M. Sendtner (1992)
10.1002/ANA.410150411
Autosomal dominant inheritance of hereditary canine spinal muscular atrophy
G. Sack (1984)
10.1002/AJMG.1320420428
Mitochondrial ATP synthase subunit c storage in the ceroid-lipofuscinoses (Batten disease).
D N Palmer (1992)
10.1002/CNE.903420106
Further characterization of the effects of brain‐derived neurotrophic factor and ciliary neurotrophic factor on axotomized neonatal and adult mammalian motor neurons
R. Clatterbuck (1994)
10.1002/NEU.480070407
Fast axonal transport in motor nerve regeneration.
J. Griffin (1976)
10.1002/NEU.480230916
Neuronal degeneration in human diseases and animal models.
D. Price (1992)
10.1016/0092-8674(94)90048-5
Functions of the neurotrophins during nervous system development: What the knockouts are teaching us
W. Snider (1994)
10.1016/0014-4886(91)90066-L
Recombinant human nerve growth factor prevents retrograde degeneration of axotomized basal forebrain cholinergic neurons in the rat
V. Koliatsos (1991)
10.3109/01677068609106858
Autosomal dominance in a late-onset motor neuron disease in the mouse.
A. Messer (1986)
10.1126/SCIENCE.1589758
Triplet repeat mutations in human disease.
C. Caskey (1992)
Pathology-light microscopy of amyotrophic lateral sclerosis. In: Handbook of Amyotrophic Lateral Sclerosis
S. M. Chou (1992)
10.1038/364584A0
ALS, SOD and peroxynitrite
J. Beckman (1993)
10.1007/978-3-642-77609-0
Free Radicals in the Brain
L. Packer (1992)
10.1038/352077A0
Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy
A. L. Spada (1991)
10.1016/0006-8993(91)90560-I
Reductions in acidic amino acids andN-acetylaspartylglutamate in amyotrophic lateral sclerosis CNS
G. Tsai (1991)
10.1016/0022-510X(84)90199-0
Neurofibrillary axonal swellings and amyotrophic lateral sclerosis
M. Delisle (1984)
CNS. Brain Res
10.1038/360753A0
Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death
Q. Yan (1992)
10.1126/SCIENCE.8351519
Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase.
H. X. Deng (1993)
10.1016/0197-4580(92)90069-A
Toxicity of synthetic aβ peptides and modeling of alzheimer's disease
D. Price (1992)
Juvenile amyotrophic lateral sclerosis and related syndromes.
M. Ben Hamida (1991)
Accumulation of the adenosine triphosphate synthase subunit C in the mnd mutant mouse. A model for neuronal ceroid lipofuscinosis.
C. Pardo (1994)
10.1016/0166-2236(93)90039-O
Excitotoxic neuronal cell death in amyotrophic lateral sclerosis
S. Appel (1993)
10.1002/ANA.410330408
Motor neuron degeneration of mice is a model of neuronal ceroid lipofuscinosis (Batten's disease)
R. Bronson (1993)



This paper is referenced by
10.1007/978-3-662-22516-5_7
Oxidative Stress in Amyotrophic Lateral Sclerosis
I. Ceballos-Picot (1997)
10.1016/S0079-6123(08)63214-8
Role of endogenous nitric oxide and peroxynitrite formation in the survival and death of motor neurons in culture.
A. Estévez (1998)
10.1093/emboj/21.3.202
Post‐natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration
G. Mallucci (2002)
10.1177/096368970000900404
Evaluation of an Intrathecal Immune Response in Amyotrophic Lateral Sclerosis Patients Implanted with Encapsulated Genetically Engineered Xenogeneic Cells
A. Zurn (2000)
10.1046/j.1471-4159.2002.00830.x
Co‐administration of IGF‐I and glycosaminoglycans greatly delays motor neurone disease and affects IGF‐I expression in the wobbler mouse: a long‐term study
A. Gorio (2002)
La sous-unité lourde des neurofilaments (NFH): du gène à la pathologie
F. Letournel (2007)
10.1046/j.1460-9568.1999.00730.x
Long‐term neuroprotective effects of glycosaminoglycans–IGF‐I cotreatment in the motor neuron degeneration (mnd ) mutant mouse
A. Gorio (1999)
10.1073/PNAS.95.22.12912
Nitration of γ-tocopherol and oxidation of α-tocopherol by copper-zinc superoxide dismutase/H2O2/NO2−: Role of nitrogen dioxide free radical
R. Singh (1998)
10.1385/MN:28:1:65
The wobbler mouse
S. Boillée (2007)
10.1006/exnr.1997.6713
Electrophysiological Properties of Dorsal Lateral Geniculate Neurons in Brain Slices from ME7 Scrapie-Infected Mice
C. J. Black (1998)
10.1139/O95-069
Alterations of intermediate filaments in various histopathological conditions.
M. Cadrin (1995)
10.1006/mcne.1998.0708
Regulation of Growth Factor Gene Expression in Degenerating Motoneurons of the Murine Mutantwobbler: A Cellular Patch-Sampling/RT–PCR Study
Marie-Pierre Junier (1998)
10.1038/NG0295-197
Rescue of neurophysiological phenotype seen in PrP null mice by transgene encoding human prion protein
M. Whittington (1995)
10.1210/ER.2006-0050
Novel perspectives for progesterone in hormone replacement therapy, with special reference to the nervous system.
M. Schumacher (2007)
10.1007/s003350010205
Mice, the Motor System, and Human Motor Neuron Pathology
Sharon J. Nicholson (2000)
10.1016/S0960-0760(02)00262-5
Basis of progesterone protection in spinal cord neurodegeneration
M. C. G. Deniselle (2002)
10.1016/S0065-3233(01)57025-4
Transgenic studies of the influence of the PrP structure on TSE diseases.
E. Asante (2001)
Title : Novel perspectives for progesterone in HRT, with special reference to the nervous system
M. Schumacher (2007)
10.1002/ANA.410420309
Increased 3‐nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation
R. Ferrante (1997)
10.1046/J.1365-2990.1998.00022.X
Phenotype analysis in neurological models of human disease.
J. Martin (1998)
10.1016/J.GHIR.2004.03.007
Local synthesis and dual actions of progesterone in the nervous system: neuroprotection and myelination.
M. Schumacher (2004)
10.1016/0022-510X(96)00084-6
An update on superoxide dismutase 1 in familial amyotrophic lateral sclerosis
M. Cudkowicz (1996)
10.1016/0896-6273(95)90259-7
An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria
P. Wong (1995)
10.1016/S0736-5748(00)00015-0
Glycosaminoglycans co-administration enhance insulin-like growth factor-I neuroprotective and neuroregenerative activity in traumatic and genetic models of motor neuron disease: a review
A. M. D. Giulio (2000)
10.1007/978-1-59259-726-0_99
Amyotrophic Lateral Sclerosis and Related Motor Neuron Diseases
M. Cudkowicz (1998)
10.1016/j.expneurol.2005.06.015
Progesterone restores retrograde labeling of cervical motoneurons in Wobbler mouse motoneuron disease
M. C. G. Deniselle (2005)
10.1038/370295A0
Prion protein is necessary for normal synaptic function
J. Collinge (1994)
10.1046/j.1471-4159.2003.02055.x
Effects of injury and progesterone treatment on progesterone receptor and progesterone binding protein 25‐Dx expression in the rat spinal cord
F. Labombarda (2003)
10.1016/S0166-4328(96)02243-7
Murine models of brain aging and age-related neurodegenerative diseases
M. Jucker (1997)
10.1016/S0736-5748(02)00052-7
Defective neurite outgrowth in aphidicolin/cAMP-induced motor neurons expressing mutant Cu/Zn superoxide dismutase
K. Lee (2002)
10.1016/S0306-4522(99)00095-0
Glycosaminoglycans boost insulin-like growth factor-I-promoted neuroprotection: blockade of motor neuron death in the wobbler mouse
L. Vergani (1999)
10.1016/J.FREERADBIOMED.2004.02.038
The carbonate radical anion-induced covalent aggregation of human copper, zinc superoxide dismutase, and alpha-synuclein: intermediacy of tryptophan- and tyrosine-derived oxidation products.
H. Zhang (2004)
See more
Semantic Scholar Logo Some data provided by SemanticScholar